Throughout evolution, mammalian viruses co-evolved with their hosts and developed effective ways to counter and evade the antiviral responses of the host immune system. An international team - including VIB and CEITEC scientists - unraveled a molecular strategy used by the widespread parapox Orf virus to counter the mammalian immune system.
ORION is a new collaborative European project to explore ways in which research and funding organizations in life sciences and biomedicine can open up the way they fund, organize and do research. CRG, MDC, BI and CEITEC, each leading a work package, are among the nine partners in the project.
Community News from the Biotech Research & Innovation Centre (BRIC), Denmark
To bring science closer to high school students in Denmark and provide outreach opportunities for our many Marie S. Curie funded fellows, BRIC hosted its first hands-on training for high school students writing their 3rd year project (SRP) in life sciences back in November 2016. The topic was cancer treatment.
Registrations for the VIBes in Biosciences 2017 biannual international PhD symposium are about to take off! VIBes is an initiative from VIB and gathers young and ambitious scientists from all over the globe to enjoy a top-quality conference.
News from the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Austria
Scientists at CeMM and the Medical University of Vienna shed light at a complex immune program that starts right after birth: the study published in Cell Reports reveals how interleukin-33 signaling induced by the first breath shapes the performance of pulmonary immune cells and influences anti-bacterial defenses.
Community News from the Institute for Molecular Medicine Finland (FIMM), Finland
The recently established EV Core at the University of Helsinki is a globally unique technology core providing extracellular vesicle (EV) know-how and tools for characterization and downstream analyses of EVs.
Community News from the Max Delbrück Center for Molecular Medicine (MDC), Germany
For the CRISPR-Cas9 system to work, researchers have to design RNA sequences that specifically match the sequence of the target gene. CrispRGold, written by MDC scientists, helps to identify the most effective and specific RNA sequences. The team has also developed a mouse strain that expresses high levels of Cas9.